CASI Pharmaceuticals (NASDAQ:CASI) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a report issued on Friday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright cut their target price on shares of CASI Pharmaceuticals from $12.00 to $6.00 and set a buy rating for the company in a […]
More Stories
Hooked Protocol (HOOK) Reaches Self Reported Market Cap of $73.71 Million
Hooked Protocol (HOOK) traded up 2.4% against the US dollar during the 1 day period ending at 23:00 PM Eastern...
IDEX (IDEX) Market Capitalization Tops $34.92 Million
IDEX (IDEX) traded 1.4% lower against the US dollar during the 1 day period ending at 23:00 PM ET on...
Shiba Inu (SHIB) Achieves Market Cap of $7.62 Billion
Shiba Inu (SHIB) traded 0.9% higher against the dollar during the 1-day period ending at 23:00 PM Eastern on September...
Algorand (ALGO) Reaches Self Reported Market Capitalization of $1.01 Billion
Algorand (ALGO) traded 5% higher against the US dollar during the 1-day period ending at 23:00 PM Eastern on September...
Energy Web Token (EWT) Reaches 24-Hour Volume of $1.05 Million
Energy Web Token (EWT) traded up 0.7% against the dollar during the 1-day period ending at 23:00 PM E.T. on...
EscoinToken Price Hits $0.70 on Exchanges (ELG)
EscoinToken (ELG) traded up 0% against the dollar during the 24-hour period ending at 23:00 PM Eastern on September 7th....